New Treatments Offer Hope Against Fatal 'Brain-Eating' Amoeba Infections
A rare but deadly infection caused by the Naegleria fowleri amoeba, often referred to as the 'brain-eating' amoeba, has historically been nearly always fatal. This amoeba thrives in warm freshwater and can infect individuals when water is forced up the nose, leading to primary amebic meningoencephalitis (PAM). Recent developments in treatment, particularly the use of the drug miltefosine, have shown promise in improving survival rates. Historically, the infection has a high fatality rate, with only four survivors out of 157 confirmed cases in the U.S. between 1962 and 2022. However, recent cases have seen some success with miltefosine, which is now being used as part of a broader treatment regimen. 
